Michael Rosol | Chief Medical Officer |
Erika Eves | Vice President-Finance and Administration |
Michael Okunewitch | Maxim Group |
Mike Rigali | Private Investor |
Greetings and welcome to the Navidea Biopharmaceuticals’ Quarter Three Earnings Call and Business Update. [Operator Instructions] And as a reminder this conference call is being recorded. It is now my pleasure to introduce Dr. Michael Rosol, Chief Medical Officer. Thank you, Michael.